"VISTA steht für hochstehende medizinische Leistung und eine umfassende Patientenbetreuung im Bereich der Augenheilkunde."

During the past decade, Vista Klinik Ophthalmologische Klinik conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 5 clinical trials were completed, i.e. on average, 41.7% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 5 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vista Klinik Ophthalmologische Klinik" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Vista Klinik" with 3 trials sponsored, "Dr. med. Katja Hatz" with 2 trials sponsored, "Allergan" with 1 trials sponsored and "PD Dr. med. Katja Hatz" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vista Klinik Ophthalmologische Klinik" #1 collaborator was "Cenaug Foundation" with 1 trials as a collaborator, "Novartis" with 1 trials as a collaborator, "University Hospital, Basel, Switzerland" with 1 trials as a collaborator and "Vista Klinik" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Vista Klinik Ophthalmologische Klinik" are "Neovascular Age-related Macular Degeneration" (3 trials), "Diabetic Macular Edema" (2 trials), "Geographic Atrophy" (2 trials), "Macular Degeneration" (2 trials) and "Age Related Macular Degeneration" (1 trials). Many other conditions were trialed in "Vista Klinik Ophthalmologische Klinik" in a lesser frequency.

Most popular intervention types in "Vista Klinik Ophthalmologische Klinik" are "Drug" (10 trials), "Other" (6 trials), "Device" (2 trials), "Procedure" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (5 trials), "Faricimab" (4 trials), "Ranibizumab" (3 trials), "Aflibercept" (2 trials) and "Lampalizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Vista Klinik Ophthalmologische Klinik" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Vista Klinik Ophthalmologische Klinik". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Vista Klinik Ophthalmologische Klinik, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Vista Klinik Ophthalmologische Klinik, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".